Products Categories
| CAS No.: | 30685-43-9 |
|---|---|
| Name: | Metildigoxin |
| Article Data: | 2 |
| Molecular Structure: | |
|
|
|
| Formula: | C42H66 O14 |
| Molecular Weight: | 794.978 |
| Synonyms: | Digoxin,4'''-O-methyl- (8CI); 4'''-Methyldigoxin; 4'''-O-Methyldigoxin; 4'''-b-Methyldigoxin; Lanirapid;Lanitop; Medigoxin; Methyldigoxin; Metildigoxin; b-Methyldigoxin |
| Density: | 1.33g/cm3 |
| Melting Point: | 200-202°C (dec.) |
| Boiling Point: | 914.1°Cat760mmHg |
| Flash Point: | 270.5°C |
| Safety: | A deadly poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. A cardiotonic agent. When heated to decomposition it emits acrid smoke and irritating fumes. |
| PSA: | 192.06000 |
| LogP: | 2.87220 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- Total:0 Page 0 of 0
What can I do for you?
Get Best Price
Chemistry
IUPAC Name: Medigoxin
The MF of Medigoxin (30685-43-9) is C42H66O14.
The MW of Medigoxin (30685-43-9) is 794.965.
Synonyms of Medigoxin (30685-43-9): beta-Methyldigoxin ; Metildigoxin ; 4'''-b-Methyldigoxin ; 4'''-Methyldigoxin ; 4'''-O-Methyldigoxin ; b-Methyldigoxin ; Card-20(22)-enolide, 3-[(O-2,6-dideoxy-4-O-methyl-b-D-ribo-hexopyranosyl-(14)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(14)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3b,5b,12b)- (9CI)
Index of Refraction: 1.589
EINECS: 250-292-0
Density: 1.33 g/ml
Flash Point: 270.5 °C
Boiling Point: 914.1 °C
Uses
Medigoxin (30685-43-9) is used as organic synthesis, pharmaceutical intermediate.
Toxicity Data With Reference
| 1. | ivn-man LDLo:160 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 34 (1984),769. | ||
| 2. | orl-rat LD50:8300 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 3. | ipr-rat LD50:6200 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 4. | scu-rat LD50:5930 µg/kg | YKYUA6 Yakkyoku. Pharmacy. 31 (1980),1127. | ||
| 5. | ivn-rat LD50:4800 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 6. | orl-mus LD50:7800 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 7. | ipr-mus LD50:4800 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 8. | scu-mus LD50:9390 µg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),828. | ||
| 9. | ivn-mus LD50:4900 µg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 21 (1971),231. | ||
| 10. | ivn-cat LDLo:190 µg/kg | ARZNAD Arzneimittel |
Safety Profile
A deadly poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. A cardiotonic agent. When heated to decomposition it emits acrid smoke and irritating fumes.